The purpose of this work was to evaluate the suitability of recent US Food and Drug
Administration (US-FDA)-approved and marketed oral liquid, powder, or granule products …

The problems related to pediatric pharmacotherapeutics and medication management are
not unique to any particular country, as drug therapy problems are common causes of …

Drugs administered to children in the United States fall into two broad categories:(1) those
that have followed the US Food and Drug Administration (US-FDA) pediatric drug approval …

The lack of commercially-available pediatric drug products and dosage forms is well-known.
A group of clinicians and scientists with a common interest in pediatric drug development …

Pediatric population is a diverse group comprising of different subgroups. The use of
unlicensed and off-label medicines for treating children is widespread due to the non …

Background Many medications given to children have no commercially available, age-
appropriate formulations. This leads to manipulation of dosage forms designed for adults …

Purpose The development of a compounded oral liquid medication formulary and
subsequent implementation of revised standard formulations in a university health system …

Raw materials in pediatric formulations such as excipients, food ingredients, and active
pharmaceutical ingredients (APIs) have received significant attention from regulatory …

BACKGROUND A large number of drugs administered to children have no commercially
available formulations. As a result, health care providers and parents manipulate dosage …

Extemporaneous preparations are still widely prescribed for pediatric patients with special
treatments of certain doses and/or combinations of drugs. Several problems related to …